APP and Alzheimer disease: Based on a report that male APP/PS1 mice demonstrate impaired glucose metabolism in the glucose tolerance test as early as 2 months of age, prior to amyloid beta deposition and cognitive decline at 8–9 months of age [30], we treated male APP/PS1 mice before the onset of this AD pathogenesis (Figure 1a).